Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia

KIT exon 17 mutation is a poor prognostic factor in core-binding factor acute myeloid leukemia. However, the mutation detection method used for risk assessment is not assigned. It is necessary to verify the analytical and clinical performance before applying new methods. Herein, we firstly applied a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Cancer J
Hlavní autoři: Jang, W, Yoon, J-H, Park, J, Lee, G D, Kim, J, Kwon, A, Choi, H, Han, K, Nahm, C H, Kim, H-J, Min, W-S, Kim, M, Kim, Y
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742633/
https://ncbi.nlm.nih.gov/pubmed/26771813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky